Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigia Ruo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|June 27, 2024
P2X7 Variants in PathophysiologyAnna Pegoraro, Marianna Grignolo, Luigia Ruo, et al.
Purinergic Signalling|March 18, 2026
Latest advances on the role of P2X Receptors in colorectal inflammation and cancerLuigia Ruo, Federica Fortuna, Marianna Grignolo, et al.
Neuropharmacology|April 17, 2026
P2X receptors in immune cells: key regulators of inflammation and immune functionElena Adinolfi, Simonetta Falzoni, Federica Fortuna, et al.
Cell Death & Disease|August 4, 2025
P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axisAnna Pegoraro, Elena De Marchi, Luigia Ruo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2026
Synthesis and characterization of new P2X7 receptor antagonists as antitumor agentsMarianna Grignolo, Andrea Spinaci, Ludovica Ricci, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|June 27, 2024
P2X7 Variants in PathophysiologyAnna Pegoraro, Marianna Grignolo, Luigia Ruo, et al.
Purinergic Signalling|March 18, 2026
Latest advances on the role of P2X Receptors in colorectal inflammation and cancerLuigia Ruo, Federica Fortuna, Marianna Grignolo, et al.
Neuropharmacology|April 17, 2026
P2X receptors in immune cells: key regulators of inflammation and immune functionElena Adinolfi, Simonetta Falzoni, Federica Fortuna, et al.
Cell Death & Disease|August 4, 2025
P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axisAnna Pegoraro, Elena De Marchi, Luigia Ruo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 12, 2026
Synthesis and characterization of new P2X7 receptor antagonists as antitumor agentsMarianna Grignolo, Andrea Spinaci, Ludovica Ricci, et al.
Pageof 1